XRTX
XORTX Therapeutics Inc

2,269
Mkt Cap
$3.15M
Volume
44,030.00
52W High
$1.79
52W Low
$0.5203
PE Ratio
-1.16
XRTX Fundamentals
Price
$0.5331
Prev Close
$0.5454
Open
$0.562
50D MA
$0.7489
Beta
0.37
Avg. Volume
5.28M
EPS (Annual)
-$1.15
P/B
1.44
Loading...
Loading...
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of XORTX Therapeutics Inc?
What is the 52-week high for XORTX Therapeutics Inc?
What is the 52-week low for XORTX Therapeutics Inc?
What is XORTX Therapeutics Inc stock price today?
What was XORTX Therapeutics Inc stock price yesterday?
What is the PE ratio of XORTX Therapeutics Inc?
What is the Price-to-Book ratio of XORTX Therapeutics Inc?
What is the 50-day moving average of XORTX Therapeutics Inc?

Latest XRTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.